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Surgical department profile focused on surgical oncology improves 
significantly the outcomes of major surgery for gastric cancer
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Mariusz Szajewski1, 2, Jarosław Szefel1, 2, Jacek Wydra1, Tomasz Buczek1
Introduction. Gastrectomy for cancer remains a challenge for both the patient and the surgical team. It is regarded as 
a high-risk surgery with extensive postoperative trauma and significant morbidity and mortality. The experience in the 
preparation and selection for operative treatment and surgery itself are important factors affecting the outcome. The 
aim of the study was to analyse, on the basis of the first 6 years of departmental functioning, whether the change in 
surgical department profile from general to oncological surgery affects the outcome of major surgery for gastric cancer. 
Materials and methods. Data collected from 114 consecutive patients that underwent major surgery for gastric 
cancer in the first 6 years of activity of our department were retrospectively reviewed. The department was created 
on the basis of a previously existing general surgery unit. There were 87 radical and 27 palliative resections. Total gas-
trectomy was the most common procedure (84%). The material was divided into 2 groups: patients who underwent 
surgery during first 3 years of the department’s existence (group I, n = 47) and patients who underwent surgery in 
the second 3-year period (group II, n = 67). 
Results. In the second three-year period we found: a higher mean age of patients (67.7 vs 63.1 years), a higher rate 
of artificial feeding applied (94% vs 66%), a higher mean number of harvested lymph nodes (21.3 vs 15.9), a lower 
rate of oesophageal anastomosis leak (0 vs 8.5%) and an improved 2-year survival rate (62.7% vs 44.7%). All of the 
mentioned differences exceeded the level of statistical significance. Postoperative mortality was 1.5% in group II and 
8.5% in group I (p > 0.05).
Conclusion. A surgical department profile focused on surgical oncology improves the outcome of major surgery 
for gastric cancer.
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Introduction
Gastric cancer ranks fourth on the list of causes of death 
in cases of oncological diseases in Europe and second on a 
global scale [1, 2]. For many years, total gastrectomy with 
an adequate lymphadenectomy has remained a standard 
procedure in the radical treatment of gastric cancer in spite 
of significant developments in combined treatments with 
the use of chemotherapy and radiotherapy [1–4]. Partial 
or subtotal resection is an admissible method of palliative 
treatment of gastric cancer, of radical treatment of some 
selected forms of this with peripheral location as well as — 
apart from endoscopic methods — it is used for the treat-
ment of early stages of gastric cancer [2]. At least 15 lymph 
nodes are required in the dissected specimen in order to 
apply the TNM system to determine the stage of disease 
progression [2]. 
The indicators of 5-year survival in European countries 
and the USA do not exceed 30% [3, 5, 6]. Therapeutic deci-
sions concerning the treatment of a patient with a gastric 
cancer should be taken within a multidisciplinary team, 
thanks to which chemotherapy more and more frequently 
precedes gastric resection. The creation of a multidisci-
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plinary team is easier in an oncological centre. However, 
in the case of surgical patients, the course of treatment is 
determined by the team in the surgical department. Gastrec-
tomy in cancer is connected with a significant perioperative 
trauma, perioperative mortality of a few per cent and poses 
a large challenge for the surgical and assistant team. Surgical 
skills, including the number of gastric resections performed 
within a year, also constitute significant prognostic factors 
in this disease [1]. 
These prognostic factors make up an image of the “sur-
gical school” of the treatment of the gastric cancer. What 
matters in this school is also the patient care before the 
commencement of surgical treatment, in the process of the 
patient preparation and qualification for a surgery. Another 
element, apart from the actual procedure of gastric resec-
tion, is the perioperative and post-operative care, along with 
an adequate procedure for decreasing the risk of morbidity 
in these periods and the ability to diagnose complications 
in a due course and to react adequately to their occurrence. 
Within the process of creating a surgical school all team 
members taking care of the patient play a significant role, 
although the team leader always takes the key role.  The 
oncological surgery department in this hospital was opened 
on 1 August 2006 and was created on the foundations of 
the previous general surgery department. The majority of 
the new team were general surgeons from the previous 
department. The new team was founded by a surgeon with 
25-years of experience at the university clinic in oncological 
surgery with a specialisation in general surgery and onco-
logical surgery. The clinic has always treated GI tract cancers 
and offered selective treatment for patients with cancer. 
When the department was created in 2006 only 2 surgeons 
(including the team’s founder) out of 8 people making up 
the team at that time had a specialisation in oncological 
surgery, apart from the specialisation in general surgery. 
Before 2006, in the general surgery department approxi-
mately 10 resection procedures were performed annually 
for gastric cancer. During the first years of the department’s 
existence, 8 surgeons received specialisation qualifications 
in oncological surgery and the department was completely 
profiled towards cancer treatment, with a majority of cases 
within the GI tract. 
The objective of this paper is to analyse changes in the 
quality of immediate and long-term results in the treatment 
of gastric cancer by the newly created oncological surgery 
department set up in an oncology centre for the treatment 
of malignant cancers within the first 6 years of the unit’s 
existence. 
Materials and methods 
The analysis took into account 114 patients undergoing 
resection procedure for gastric cancer within the first 6 years 
of the existence of the Oncological Surgery Department of 
the Oncology Centre in Gdynia. There were 87 radical and 
27 palliative resections performed. A majority of procedures 
were gastrectomy surgeries (n = 91, 79.8%), including 5 
multi-organ resections (4.4%). In 18 cases partial gastric 
resection was performed (15.8%), and in 5 cases (4.4%) 
— a resection of the gastric stump was performed for the 
cancer in the stump. After the gastrectomy, the continuity 
of the GI tract was restored with Roux en Y method.  The 
study sample was divided into two groups: the patients 
operated on within the first 3 years of the department’s 
existence (group I, n = 47) and the patients operated on in 
the next 3 years (group II, n = 67). The analysis accounted for 
the age of the patients, the distribution of the pTNM stage 
(for statistical purposes stage 1 was grouped with stage 2, 
and stage 3 with 4), the total number of the resected lymph 
nodes, the percentage of splenectomies and the frequency 
of administration of artificial nutrition in the perioperative 
period, the amount of the transfused blood, the general 
number of complications and leaks of the oesophageal 
anastomosis, perioperative mortality and 2-year survival. 
The perioperative death was defined as the death during the 
hospitalisation period or the death after discharge within 
30 days of the procedure. Table I contains a presentation of 
the factors concerning the characteristics of the patients and 
the applied type of treatment as compared in both groups.
Statistical analysis 
The statistical analysis was performed with the STATIS-
TICA data analysis software system, version 10, produced by 
StatSoft, Inc. (2011). The chi2Pearson and U Mann-Whitney 
tests and Pearson correlation analyses were used. For the 
survival analysis, the Kaplan-Meier method was applied 
and the difference between the groups was verified with 
the log-rank test. The results were regarded as significant 
with p < 0.05.
Results 
The groups were compared in respect to the TNM stages 
according to the score and the type of the procedure per-
formed. In group II, the median age was significantly higher 
and artificial nutrition was used much more frequently. 
The results of treatment in specific periods are presented 
in Table II.
In group II the average number of resected lymph nodes 
was higher and the rate of leaks of the oesophageal anas-
tomosis was lower, and the 2-year survival rate was found 
to be higher. The 24-month survival curves within the two 
groups of the patients are presented in Figure 1.
No correlation between the use of the artificial nutrition 
and the frequency of the post-operative complications, in-
cluding the leak of the oesophageal anastomosis was found. 
Also no correlation between the number of resected lymph 
nodes and the survival period was observed. However, a 
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strong correlation (p = 0.000001) between the number of 
lymph nodes involved with the cancer metastases and the 
number of all resected metastases was calculated jointly for 
all the patients (Fig. 2). The patients with a 2-year survival 
had a similar number of the lymph nodes resected as those 
who died within the 2-year observation period (18.9 vs 
19.3; ns). They also had a similar average nodal index (0.24 
vs 0.31; ns).
Discussion
Invasive forms of gastric cancer continue to have a poor 
prognosis — this is why each potentially prognostic factor 
in this disease requires a thorough analysis. A potentially 
better prognosis is guaranteed by treatment in a highly 
specialised centre [7–10]. The annual number of gastrec-
tomies, which would allow for a facility to be characterised 
as ‘highly specialised’ still remains disputable. Enzinger et 
al. evaluated the correlation between the annual number 
of total gastric resections in a specific department and the 
treatment outcomes. These authors regarded 14 gastrec-
tomies per year as a high correlation co-efficient [7]. Large 
European academic treatment centres report 11.4–24.2 re-
section procedures annually [11–13]. In a study by American 
authors concerning gastrectomy in patients above 65 years 
of age with gastric cancer and treated in oncology centres 
and hospitals with a “large” number of surgeries, the median 
number for gastrectomies was 21 (scope 5–137) in oncol-
ogy centres, and 30 (scope 25–69) in hospitals with a “large” 
number of surgeries [14]. In our sample the annual number 
of gastrectomies performed for adenocarcinoma grew from 
15.6 in the first period to 22.3 in the 3 following years. In the 
European context, these figures place our department (with 
the experience of the three last years) in the group of high 
specialisation centres.
Facilities performing a high number of extensive surgi-
cal operations are generally larger, better equipped and 
have a highly-trained multidisciplinary team. This facilitates 
more effective diagnostics and treatment of gastric cancer 
without any unnecessary delays at its various stages. Our 
department has the structure of an oncological centre, 
which makes it easier to take multidisciplinary decisions in 
our approach towards a patient with a gastric cancer. The 
multidisciplinary treatment process has taken hold in the 
second period of the activity in our department.  
The better physical condition of a patient is another 
cause for better outcomes in treatment in large institutions 
with centralisation in diagnostics and multidisciplinary treat-
ment. Usually, patients in a better physical condition are 
referred to larger, but still, very few centres far away from 
their places of residence, as such patients are able to sustain 
a longer journey to hospital [9, 14]. A comparison of various 
treatment centres for  gastric cancer made by Smith et al. 
suggests that in the hospitals with the largest number of 
total gastric resections the rate of patients above 75 years 
of age was 15%, while in smaller, i.e. non-centralised cen-
tres — as much as 36%. The patients from smaller centres 
were more frequently burdened with comorbidities and 
they more often required the admission on an urgent basis, 
which generally fostered poorer outcomes of treatment 
[10]. In our case, from the moment of the creation of the 
department and for the entire 6-year period of observation, 
we have not found any significant differences in the selec-
Table I. Characteristics of the patients and the applied treatment of study groups
Total Group I (n = 47) Group II (n = 67) p value
Average age (median) (years) 65.8 (67.5) 63.1 (63) 67.7 (70) p = 0.03
pTNM 
0+I 18 9 19 9 ns
II 29 10 (40.4%) 28 (41.8%) 19
III 49 16 33
IV 18 12 28 (59.6%) 6 39 (58.2%)
Early cancer 11 (9.6%) 4 (8.5%) 7 (10.4%) ns
Artificial feeding 94 (82.5%) 31 (66%) 63 (94%) p = 0.0001
Type of procedure
Gastrectomy 91 (79.8%) 35 (74.5%) 56 (83.6%) ns
Extended 5 (4.4%)  0 5 (7.5%)
Total resections of the stomach stump 5 (4.4%) 3 (6.4%) 2 (3.0%)
Resection 
Total/Subtotal 18 (16.8%) 9 (19.1%) 9 (13.4%)
Radical 87 32 (68.1%) 55 (80.3%)
Palliative 27 15 (31.9%) 12 (19.7%) ns
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tion of the patients for surgical interventions. The quality 
of the equipment used for gastric resection procedures has 
also remained unchanged. The most significant changes 
leading to the improvement of treatment outcomes are, in 
our opinion: the specialisation of the department towards 
oncological procedures and comprehensive training of the 
surgical and nursing teams towards the care of oncological 
patients (usually these are elderly patients). In our case, gain-
ing experience together in the treatment of older patients 
with gastric cancer was translated to a higher median age 
of the patients treated within the last 3 years of the analysed 
period. The mean and median age in the patients in the 
second of the analysed periods was significantly higher. 
Surgeons and anaesthesiologists more frequently qualified 
for the surgical treatment of elderly patients, who were also 
often burdened with comorbidities.
An increase of the number of patients operated on for 
early gastric cancer is naturally conducive to the improve-
ment of outcomes in the treatment of this disease [11, 12]. 
Among our patients, the distribution of the advancement 
stages of gastric cancer was similar in both study periods. It 
is worth observing that Poland still remains within a group 
of countries in Europe with lower survival rates for gastric 
cancer [15]. The aggregate rate of early gastric cancers in 
our sample was 9.6% for both groups and the difference be-
tween the two groups was insignificant. In Western Europe 
and in the USA this rate amounts to approximately 20% [13].
The general rate of complications reported by different 
centres varies significantly and in some instances was as 
much as 39% [3]. We have observed a significant heteroge-
neity in defining and reporting complications. In our study 
sample, this rate decreased by almost half within a short 
period, yet this difference has not reached the level of sta-
tistical significance. A universal exponent of the quality of 
a gastrectomy procedure is the rate of oesophageal anas-
tomosis leak. It varies, depending on the source, from 1.6% 
to 8% [9, 11–13, 16]. In our department, we have managed 
to decrease the rate of anastomosis from a relatively high 
one (8.5%) to zero in group II (Tab. II).
A significant element which points to the quality of the 
treatment of GI tract cancers in a given centre, is the rate of 
perioperative mortality. It is especially significant in the case 
of surgical treatment of oesophageal and pancreatic cancer 
[7, 8, 17–19]. Perioperative mortality following gastrectomy 
Figure 2. Correlation between the metastatic lymph nodes and the 
number of all resected lymph nodes
Figure 1. 24-month survival curves in both groups
Table II. Results of surgical treatment in both groups of patients
Group I (n = 47) Group II (n = 67) Statistical analysis
Average number of resected lymph nodes (median) 15.9 (16) 21.3 (19) p = 0.01
Average number of metastatic lymph nodes (median) 7.0 (4) 4.8 (2) ns
Nodal index 0.35 0.21 ns
Splenectomies’ rate 19.1% 11.9% ns
Average number of PRBCs transfused (median) 1.8 (2) 2.3 (2) ns
General rate of complications 27.7% 14.9% ns
The rate of oesophageal anastomosis leak 8.5% 0% p = 0.01
The rate of perioperative mortality 8.5% 1.5% ns
2-year survival rate 44.7% 62.7% p = 0.05
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procedure in some European countries and in the USA fre-
quently exceeds 5%. Only some centres report the number 
of perioperative deaths on the level of 2% [4, 8, 11, 12, 16, 
18]. The values obtained in our study (Tab. II) prove the im-
provement of the entire patient care, however the difference 
between the studied groups, although clearly observable, 
has not reached the level of statistical significance.
An increase in the number of resected lymph nodes is 
another factor in the improvement of the quality of stomach 
cancer surgery [1]. Although the therapeutic value of exten-
sive lymphadenectomy still remains a controversial issue, 
it definitely affects a more precise evaluation of the cancer 
advancement stage [1, 16, 18, 20]. The authors of the study, 
which is based on the results of 1853 radical gastrectomies 
from 6 Italian centres, proved almost an identical rate of 
5-year survival in the groups above and below 15 resected 
lymph nodes [21]. Some authors propose the nodal index as 
a prognostic factor, i.e. the rate of the lymph nodes involved 
with cancer metastases to the overall number of resected 
lymph nodes [20, 21]. Our sample did not show any prog-
nostic value of the rate calculated in this way in relationship 
to a two-year survival. The intention of the majority of lym-
phadenectomies performed in our centre, as declared by the 
surgeons, was the scope of the nodes:  D2. We have shown 
a strong positive correlation between the overall number 
of resected lymph nodes and the number of lymph nodes 
involved with metastases (Fig. 2). Some similar results were 
obtained by other authors [6, 10, 20–22]. Although, in our 
study sample, the number of lymph nodes with metastases 
was lower on group II, the difference between the groups 
did not reach the level of statistical significance (p = 0,3). 
The presence of lymph nodes affected with metastases 
macroscopically fosters a larger number of nodes resected 
by the surgeon as well as a larger number of nodes found by 
the pathologist in the specimen. In our sample, however, in 
the second observation period the number of lymph nodes 
evaluated by the pathologist was significantly higher in the 
initial period of the department’s existence and the mean 
and median number of the metastatic lymph nodes was 
lower. This is indirectly conducive to a better technique of 
gastric resection procedure. 
We regard the core achievement of the team to be the 
increase of the 2-year survival rate in group II to 62.7%, with a 
zero rate of clinically overt oesophageal anastomosis leak in 
the second of the two 3-year evaluation periods. It is worth-
while to stress that the majority of patients in both groups 
had 3rd and 4th stage cancer. A comparison of treatment 
outcomes for gastric cancer in the Netherlands, Denmark, 
Sweden and England shows that 2-year survival rate after 
a gastrectomy for cancer falls between 51.7%–56.3% [5].
Undeniably, a significant prognostic role is still played 
by the operating surgeon [1]. An increase in the number of 
surgeons in the departments  specialising in general surgery 
and oncological surgery and the many years of experience 
in the care of only cancer patients seems to be the likely 
cause of the significant decrease of the risk of oesophageal 
anastomosis leak after stomach resection in the ward. The 
increase in nutritional treatment in the periods preceding 
and following surgery is also a probable cause of decreased 
morbidity and better treatment outcomes in the second 
period analysed in the study.
Conclusions 
The model of a surgical department focused solely on 
the treatment of cancers and functioning within the struc-
ture of an oncological centre fosters improvement in the 
treatment of patients with resectable gastric cancer. 
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